Fairvalue-Calculator Fairvalue-Calculator
EN DE

Positive Physicians Holdings (PPHI) Fair Value & Analysis

Financial Services · US · Market cap $27.1M

Price$8.50
Fair Value$12.41
Upside+46.0%
Quality89/100
Evidence: Low Range $9.83 – $14.98

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Positive Physicians Holdings (PPHI) currently trades at $8.50, while our model-based Fair Value estimate is $12.41 — implying the stock looks roughly 46.0% undervalued today. We read business quality at 89/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Positive Physicians Holdings, Inc., through its subsidiary, provides insurance products in the United States. The company offers medical professional liability protection, including claims-made coverage, occurrence coverage, and customized rating structures; and risk management services. It serves physicians, physician groups, and healthcare professionals. The company was founded in 2002 and is based in Bala Cynwyd, Pennsylvania. Positive Physicians Holdings, Inc. operates as a subsidiary of Insurance Capital Group, LLC.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Positive Physicians Holdings (PPHI) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $12.41 versus a price of $8.50 — about +46% (undervalued). Model-based estimate, not financial advice.
What is the fair value of PPHI?
Our 21-model fair value for Positive Physicians Holdings is $12.41 (as of Jun 26, 2026), built from audited fundamentals. The current price is $8.50.
What is the quality score of PPHI?
Positive Physicians Holdings has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.